Grandfield & Dodd, LLC Astrazeneca PLC Transaction History
Grandfield & Dodd, LLC
- $1.53 Billion
- Q4 2024
A detailed history of Grandfield & Dodd, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Grandfield & Dodd, LLC holds 6,505 shares of AZN stock, worth $484,297. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,505
Previous 7,426
12.4%
Holding current value
$484,297
Previous $578,000
26.3%
% of portfolio
0.03%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,341Shares Held
477MCall Options Held
5.39MPut Options Held
3.29M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.68 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.05 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.79 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.76 Billion0.46% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.45 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...